|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Multiple Myeloma |
1.00 |
12/23/2020 - 12:00am to 05/23/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer |
1.00 |
11/30/2020 - 12:00am to 03/14/2021 - 12:00am |
|
Multidisciplinary Management of Advanced Kidney Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Myeloproliferative Neoplasms: Emerging Treatment Options for Myelofibrosis |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Navigating the Jargon of Molecular Testing |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
NCCN Guidelines® Insights - Acute Myeloid Leukemia, Version 2.2021 |
1.00 |
01/10/2021 - 12:00am to 01/10/2022 - 12:00am |
|
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2020 |
1.00 |
06/10/2020 - 12:00am to 06/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Colorectal Cancer Screening, Version 2.2020 |
1.00 |
10/10/2020 - 12:00am to 10/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 |
1.00 |
04/10/2020 - 12:00am to 04/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Kidney Cancer, Version 1.2021 |
1.00 |
09/10/2020 - 12:00am to 09/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Management of Immunotherapy-Related Toxicities, Version 1.2020 |
1.00 |
03/10/2020 - 12:00am to 03/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Primary Cutaneous Lymphomas, Version 2.2020 |
1.00 |
05/10/2020 - 12:00am to 05/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Rectal Cancer, Version 6.2020 |
1.00 |
07/10/2020 - 12:00am to 07/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Soft Tissue Sarcoma, Version 1.2021 |
1.00 |
12/10/2020 - 12:00am to 12/10/2021 - 12:00am |
|
NCCN Guidelines® Insights - Survivorship, Version 2.2020 |
1.00 |
08/10/2020 - 12:00am to 08/10/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward